Skip to main content
. Author manuscript; available in PMC: 2018 Feb 20.
Published in final edited form as: Int Rev Cell Mol Biol. 2016 Jul 30;327:43–87. doi: 10.1016/bs.ircmb.2016.06.006

Figure 14.

Figure 14

Activation of caspase-2 by FASN inhibitors is mediated by the mTOR pathway. Upon FASN inhibition, the mTOR inhibitory protein REDD1 is induced and stimulates caspase-2 activation and apoptosis in FASN-sensitive ovarian cancer cells. On the other hand, in FASN-resistant ovarian cancer cells, REDD1 induction is impaired, but mTOR inhibitor treatment can substitute function of REDD1 and restore caspase-2-mediated sensitization of cells to apoptosis.